Xencor Inc (XNCR)

↓ Download CSV

CIK 0001326732 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Xencor Inc reported revenue of $125.58M, up 13.7% from the prior year. The company ran a net loss, with a net margin of -73.2%. It held $875.50M in total assets against $239.91M in total liabilities.

Key ratios (FY2025)

-141.4%
Operating margin
-73.2%
Net margin
-14.5%
Return on equity
+13.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$125.58M$110.49M$174.62M$164.58M$275.11M$122.69M$156.70M$40.60M$46.15M$109.02M
Operating Income-$177.50M-$178.41M-$132.36M-$82.47M$43.77M-$76.80M$13.82M-$79.37M-$43.12M$44.04M
Net Income-$91.92M-$232.62M-$133.13M-$55.18M$82.63M-$69.33M$26.88M-$70.41M-$38.49M$45.12M
EPS (Diluted)$-1.24$-3.58$-2.20$-0.93$1.37$-1.21$0.46$-1.31$-0.82$1.07
Total Assets$875.50M$951.95M$965.13M$846.27M$838.21M$703.24M$670.25M$576.73M$390.20M$428.56M
Total Liabilities$239.91M$277.92M$303.05M$118.77M$104.71M$130.80M$77.05M$55.05M$73.74M$114.61M
Shareholders' Equity$635.59M$677.61M$661.75M$727.50M$733.50M$572.44M$593.20M$521.68M$316.46M$337.93M
Cash & Equivalents$54.07M$40.88M$53.79M$53.94M$143.48M$163.54M$50.31M$26.25M$16.53M$14.53M
Operating Cash Flow-$135.12M-$202.19M-$77.93M$24.48M-$16.85M-$5.00M$64.37M-$79.76M-$33.60M$95.24M
Capital Expenditures$3.15M$6.10M$18.45M$38.49M$13.30M$10.54M$7.35M$7.21M$5.31M$1.51M
Shares Outstanding74.24M65.04M60.50M59.65M60.50M57.21M58.47M53.94M46.82M42.39M